Anjana Munshi

Central University of Punjab India

Professor Anjana Munshi, M.Sc, M.Phil, Ph.D., is head of the Department of Human Genetics and Molecular Medicine at the Central University of Punjab, Bathinda, Punjab, India. She is also Dean for the School of Health Sciences and Dean of Research at the Central University of Punjab. Her expertise includes stroke genetics, hemoglobinopathies, pharmacogenetics, molecular cancer biology, epilepsy and bioinformatics. She has published 125 papers in international peer reviewed journals and contributed to 20 book chapters in books published by reputed international publishing houses. She is a reviewer for several international research journals of global reputation.

2books edited

2chapters authored

Latest work with IntechOpen by Anjana Munshi

The book, Inherited Hemoglobin Disorders, describes the genetic defects of hemoglobins, disease complications, and therapeutic strategies. This book has two distinct sections. The first theme includes seven chapters devoted to the types of hemoglobinopathies, mutation spectrum, diagnostic methods, and disease complications, and the second theme includes three chapters focusing on various treatment strategies. The content of the chapters presented in the book is guided by the knowledge and experience of the contributing authors. This book serves as an important resource and review to the researchers in the field of hemoglobinopathies.

Go to the book

Inherited Hemoglobin Disorders

Edited by Anjana Munshi

Books edited

DNA Sequencing

Edited by Anjana Munshi

Chapters authored

Pharmacogenetics - A Treatment Strategy for Alcoholism

By Anjana Munshi and Vandana Sharma

Part of the book: Pharmacology

Modifiers of γ-Globin Gene Expression and Treatment of β-Thalassemia

By Anjana Munshi, Sneha Dadeech, M. Sai Babu and Preeti Khetarpal

Beta thalassemia (β-thalassemia) is an autosomal recessive genetic disease with many genes involved. It is a heterogeneous disorder caused by variations in the inactivation mechanism of the Beta-globin (β-globin) genes. Despite seemingly similar genotypes, the patients with Beta-thalassemia have a remarkable variability in anaemia, growth development, and hepatospleenomegaly and transfusion requirements. The genetic factors may differ in each race or ethnic group for therapy and prevention. Despite remarkable successes in the treatment of Beta-thalassemia in the past decades, it is still the leading cause of death and premature disability in developed and developing countries. Possible factors that influence the severity of anaemia in thalassemia may be inherited or non-inherited. The inherited factors include the type of β-thalassemia, coinheritance of alpha thalassemia (α-thalassemia) and factors that stimulate fetal hemoglobin (HbF) production. In this chapter, respective contributions of known modifiers and also the pharmaceutical agents currently in use and under clinical trials for regulating the globin gene expression will be discussed.

Part of the book: Inherited Hemoglobin Disorders

Anjana Munshi

Latest work with IntechOpen by Anjana Munshi

Inherited Hemoglobin Disorders

Books edited

DNA Sequencing

Chapters authored

Related collaborators

Cyril Goudet

Gregory Stewart

Julie Kniazeff

Philippe Rondard

Laurent Prezeau

Jean-Philippe Pin

Norifumi Yonehara

Motohide Takemura

Akira Furuyama

You-Hong Jin